Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Rat Anti-Mouse CD90-APC (G7)

Cat. No.:
APC Anti-Mouse CD90 antibody for use in flow cytometry assays.
Size Price (USD) Quantity
0.1 mg $286.00
More Information
Clone G7
Isotype Rat (Lewis) IgG2cκ
Isotype Control Rat IgG2c-APC (SB68b)
Specificity Mouse CD90 (Thy-1.1 and Thy1.2 alloantigens/CD90.1 and CD90.2)
Alternative Names Thy-1
Description CD90 (Thy-1), a GPI-anchored molecule and one of the smallest members of the immunoglobulin superfamily of cell surface receptors, consists of a single V-set domain. It is expressed on thymocytes, peripheral T lymphocytes, some intraepithelial T lymphocytes, and neurons of all mouse strains. The monoclonal antibody G7 stimulates T-cell proliferation and IL-2 secretion via signaling through the T-cell receptor/CD3 complex. G7 has also been reported to promote apoptosis of thymocytes and CTL clones and to mediate adhesion of thymocytes to thymic stroma.
Immunogen Mouse T cell hybridoma C6/G8
Conjugate APC (Allophycocyanin)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer
Clonality Monoclonal
Concentration 0.1 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light; Do not freeze
Applications Flow Cytometry – Quality tested 1,6-8
Immunohistochemistry-Paraffin Sections – Reported in literature 4
Immunoprecipitation – Reported in literature 1
Stimulation – Reported in literature 1
Activation – Reported in literature 1,5
Apoptosis – Reported in literature 2,3

RRID Number AB_2795227
Gene ID 21838 (Mouse)
Gene ID Symbol Thy1 (Mouse)
Gene ID Aliases T25; CD90; Thy-1; Thy1.1; Thy1.2; Thy-1.2
UniProt ID P01831 (Mouse
UniProt Name THY1_MOUSE (Mouse)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Gunter KC, Malek TR, Shevach EM. T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4. J Exp Med. 1984;159:716-30. (Immunogen, FC, IP, Stim, Activ)
  2. 2. Ucker DS, Meyers J, Obermiller PS. Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J Immunol. 1992;149:1583-92. (Apop)
  3. 3. Hueber A, Raposo G, Pierres M, He H. Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J Exp Med. 1994;179:785-96. (Apop)
  4. 4. Whiteland JL, Nicholls SM, Shimeld C, Easty DL, Williams NA, Hill TJ. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem. 1995;43:313-20. (IHC-PS)
  5. 5. Kojima H, Toda M, Sitkovsky MV. Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells. Int Immunol. 2000;12:365-74. (Activ)
  6. 6. Kucic T, Copland IB, Cuerquis J, Coutu DL, Chalifour LE, Gagnon RF, et al. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia. Am J Physiol Renal Physiol. 2008;295:F488-96. (FC)
  7. 7. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood. 2005;106:4057-65. (FC)
  8. 8. Xiao J, Angsana J, Wen J, Smith SV, Park PW, Ford ML, et al. Syndecan-1 displays a protective role in aortic aneurysm formation by modulating T cell-mediated responses. Arterioscler Thromb Vasc Biol. 2012;32:386-96. (FC)
See All References